Nov

    International Antitrust Developments: April 2017 through October 2017

    12 PM EST

    Join us for the fifth installment of the International Antitrust Developments Initiative, a series of semiannual programs on antitrust developments in health care and pharmaceuticals outside of the U.S. The program on November 29, 2017, presented by Cleary Gottlieb, will cover enforcement developments in merger control, restrictive agreements, and abuse of dominance in Europe and in China from April 2017 through October 2017. Approaching antitrust issues from a global perspective is especially important in these markets, as companies deal with many of the same core antitrust issues inside and outside of the U.S., but are often subject to varying standards and levels of enforcement. This presentation aims to provide in-house and external antitrust practitioners with an overview of major recent developments.

    For information about our Committee membership, please contact Philip Nelson (nelson.p@ei.com) and Jeffrey Brennan (jbrennan@mwe.com). You can also visit our LinkedIn page: ABA Health Care and Pharmaceuticals Committee

    FREE: Antitrust Section Members, Government, Non-profit Employees, Students, Other Non-Members

    Explore Section benefits or call 1-800-285-2221 to join. Code RAT14IP25. For this and all upcoming events visit http://ambar.org/atevents.

    CLE: The ABA is not seeking CLE credit for this program. Audio Archive: Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.

    $25
    NON-MEMBERS
    $10
    MEMBERS
    $0
    SECTION MEMBERS
    Register Now *Additional discounts may apply at checkout

    Log In to view your rate

    International Antitrust Developments: April 2017 through October 2017

    Event Details

    Format

    Teleconference

    Date

    Nov 29, 2017

    2017-11-29T12:00:00-05:00 2017-11-29T13:00:00-05:00 International Antitrust Developments: April 2017 through October 2017

    Join us for the fifth installment of the International Antitrust Developments Initiative, a series of semiannual programs on antitrust developments in health care and pharmaceuticals outside of the U.S. The program on November 29, 2017, presented by Cleary Gottlieb, will cover enforcement developments in merger control, restrictive agreements, and abuse of dominance in Europe and in China from April 2017 through October 2017. Approaching antitrust issues from a global perspective is especially important in these markets, as companies deal with many of the same core antitrust issues inside and outside of the U.S., but are often subject to varying standards and levels of enforcement. This presentation aims to provide in-house and external antitrust practitioners with an overview of major recent developments.

    For information about our Committee membership, please contact Philip Nelson (nelson.p@ei.com) and Jeffrey Brennan (jbrennan@mwe.com). You can also visit our LinkedIn page: ABA Health Care and Pharmaceuticals Committee

    FREE: Antitrust Section Members, Government, Non-profit Employees, Students, Other Non-Members

    Explore Section benefits or call 1-800-285-2221 to join. Code RAT14IP25. For this and all upcoming events visit http://ambar.org/atevents.

    CLE: The ABA is not seeking CLE credit for this program. Audio Archive: Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.

    Sponsors

    Health Care and Pharmaceuticals Committee

    Section of Antitrust Law

    Panelists

    Cunzhen Huang

    Niklas Maydell

    Peter Cimentarov

    Co-sponsors

    International

    Moderators

    Related Products

    Related On-Demand CLE